Sleep Study Measures on Postoperative Night 1 Following Implantation of the Hypoglossal Nerve Stimulator.

Abstract

To examine the changes in measures of sleep apnea severity and hypoxemia on the first postoperative night following implantation of the hypoglossal nerve stimulator. This was a single-arm prospective cohort study. A single academic sleep surgical practice. Subjects with moderate to severe obstructive sleep apnea underwent implantation of the hypoglossal nerve stimulator (HGNS) and were discharged to home the same day as surgery. A single-night WatchPAT study was performed on the night immediately following surgery (PON 1) and was compared to baseline sleep testing. Twenty subjects who were an average of 58.6 ± 2.5 years old, were 25% female, and had a mean body mass index of 28.1 ± 0.9 kg/m² completed the study. Mean O₂ nadir at baseline was 79.6% ± 1.1% compared to 82.7% ± 0.9% (<i>P</i> = .013) on PON 1. One patient demonstrated a >10% worsening in O₂ nadir. Only 2 additional patients demonstrated a worsening in O₂ nadir on PON 1, each by only 1 percentage point. Neither mean time spent below SpO₂ 88% nor oxygen desaturation index (ODI) worsened postoperatively (mean time spent below oxygen saturation of 88%, 27.8 ± 7.85 vs 11.2 ± 5.2, <i>P</i> = .03; mean ODI, 29.6 ± 5.2/h vs 21.0 ± 5.4/h, <i>P</i> = .10). Mean obstructive apnea hypopnea index (AHI) was no worse (40.6 ± 4.7/h to 28.7 ± 4.2/h, <i>P</i> = .02), with only 2 patients experiencing an obstructive AHI >20% more severe than baseline. Only 1 patient demonstrated a clinically meaningful increase in central AHI on PON 1. Overall, AHI and measures of nocturnal hypoxemia are stable, if not improved, on PON 1 following HGNS implantation. These findings support the safety of same-day discharge following implantation of the hypoglossal nerve stimulator.